Disease Awareness | Novartis

Media Release
Jul 29, 2024
Novartis Scemblix® granted FDA Priority Review for the treatment of adults with newly diagnosed CML
Story
Jan 31, 2024
Giving voice to people with a misunderstood disease
Story
Jan 31, 2024
Facing the fear of breast cancer recurrence
Landing Page
My Cancer. My Words.
Story
Dec 12, 2023
Innovation fueled by compassion
Story
May 09, 2023
Q&A: Addressing unmet needs for people living with PNH, a rare and chronic blood disorder
Story
Feb 04, 2023
When you think of the word ‘cancer’, what are the first words that spring to mind?
Featured News
May 23, 2022
Novartis at ASCO and EHA 2022
Story
Nov 04, 2021
Breaking down barriers for patients with sickle cell disease
Story
Oct 26, 2021
Demystifying the science of myelodysplastic syndromes
Media Release
Oct 21, 2021
Novartis signs new initial agreement with BioNTech to support fill and finish of the mRNA Pfizer-BioNTech COVID-19 vaccine
Media Release
Jan 31, 2020
Novartis Cosentyx® builds on its axSpA leadership with US label update for dosing flexibility in ankylosing spondylitis